May 24, 2017 / 5:07 AM / 2 months ago

BRIEF-Roche says data support Esbriet use in idiopathic pulmonary fibrosis

1 Min Read

May 24 (Reuters) - Roche Holding Ag

* Says new data at ats add to body of evidence for roche's esbriet (pirfenidone) in idiopathic pulmonary fibrosis Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below